Search
Lifeward Ltd
LFWDAdd to Watchlist
7.335USD
-0.325-4.24%
Market hours （ET）Quotes delayed by 15 min
20.38MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-4.24%
5 Days
+5.50%
1 Month
-7.62%
6 Months
+6.01%
Year to Date
+6.01%
1 Year
-5.20%
Key Figures
7.600Open
7.600High
5.49KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.20%Turnover Ratio
7.660Prev. Close
7.160Low
35.83KTurnover
LossP/E Static
3.24P/B
0.00%Div Yield TTM
-83.16%ROA
15.24052wk High
2.88Volume Ratio
-28.94MNet Profit
2.78MShares
-207.0822EPS TTM
0.36Beta
-209.10%ROE
4.14052wk Low
5.74%Amplitude
34.21%Gross Margin
20.38MMarket Cap
-0.68Reward/Risk
5.34%Risk Rate
TradingKey Stock Score of Lifeward Ltd
Currency: USD Updated: 2026-06-30Key Insights
Lifeward Ltd's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 100 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 20.00.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Lifeward Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Lifeward Ltd Highlights
StrengthsRisks
Lifeward Ltd, formerly known as ReWalk Robotics Ltd, is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 59.04% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 22.03M.
Overvalued
The company’s latest PE is -0.04, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 58.22K shares, decreasing 68.75% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
20.000
Target Price
+180.31%
Upside Space
Lifeward Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Lifeward Ltd Info
Lifeward Ltd, formerly known as ReWalk Robotics Ltd, is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.
Ticker SymbolLFWD
CompanyLifeward Ltd
CEOGrant (Mark Stuart)
Websitehttps://golifeward.com/
Related Instruments
+1.99%
+3.61%
+2.09%
+1.95%
+2.11%
+0.58%
+0.16%
+1.38%
+0.30%
+3.68%
+0.11%
+0.63%
+1.30%
+0.89%
+3.40%
+1.63%
+0.74%
+1.70%
+1.71%
+4.23%Popular Instruments
52710.700
+514.400 (+0.99%)
29989.600
-235.000 (-0.78%)
7518.900
+36.500 (+0.49%)
15380.000
-215.000 (-1.38%)
69936.000
-920.000 (-1.30%)
6291.200
-35.800 (-0.57%)
68.138
-1.783 (-2.55%)
295.410
+6.050 (+2.09%)
196.879
-3.211 (-1.60%)
4083.940
+76.660 (+1.91%)
FAQs
What is the current price of Lifeward Ltd (LFWD)?
The current price of Lifeward Ltd (LFWD) is 7.85.
What is the symbol of Lifeward Ltd?
The ticker symbol of Lifeward Ltd is LFWD.
What is the 52-week high of Lifeward Ltd?
The 52-week high of Lifeward Ltd is 15.24.
What is the 52-week low of Lifeward Ltd?
The 52-week low of Lifeward Ltd is 4.14.
What is the market capitalization of Lifeward Ltd?
The market capitalization of Lifeward Ltd is 21.56M.
Is Lifeward Ltd (LFWD) currently rated as Buy, Hold, or Sell?
According to analysts, Lifeward Ltd (LFWD) has an overall rating of Buy, with a price target of 20.00.
What is the Earnings Per Share (EPS TTM) of Lifeward Ltd (LFWD)?
The Earnings Per Share (EPS TTM) of Lifeward Ltd (LFWD) is -205.91.